PyInvesting

Market research

DRIO DarioHealth Corp

NASDAQ USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
71M
P/E ratio
Not available
Analyst target
14
Dividend yield
Not available
Beta
1.12

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

DarioHealth Corp is currently in a long term uptrend where the price is trading 2.8% above its 200 day moving average.

From a valuation standpoint, the stock is 98.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 16.0.

DarioHealth Corp's total revenue rose by 15.7% to $2M since the same quarter in the previous year.

Its net income has dropped by 115.6% to $-9M since the same quarter in the previous year.

Finally, its free cash flow fell by 137.2% to $-7M since the same quarter in the previous year.

Based on the above factors, DarioHealth Corp gets an overall score of 3/5.